Stimuli-Responsive Polymer–Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy-Reference-Cited by-同舟云学术

Stimuli-Responsive Polymer–Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy

Published:2019-08-05 Issue:9 Volume:19 Page:5967-5974
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Saw Phei Er¹²,Yao Herui¹²,Lin Chunhao¹²,Tao Wei³^ORCID,Farokhzad Omid C³^ORCID,Xu Xiaoding¹²^ORCID

Affiliation:

1. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China

2. RNA Biomedical Institute, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China

3. Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States

Funder

Guangdong Science and Technology Department

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Guangdong Science and Technology Department - International Scientific and Technological Cooperation Program

Guangzhou Science and Technology Bureau

?Three million for Three Years? Project of the High-level Talent Special Funding Scheme of Sun Yat-Sen Memorial Hospital

US METAvivor Early Career Investigator Award

David H. Koch-Prostate Cancer Foundation Program in Cancer Nanotherapeutics

Publisher

American Chemical Society (ACS)

Subject